These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 313270)

  • 41. [Stimulation of mitotic activity and blast transformation of lymphocytes in vitro caused by phaseolosaxin and its fractions].
    Kovachev D
    Tsitologiia; 1980 Mar; 22(3):355-7. PubMed ID: 7368313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human interleukin 2.
    Robb RJ
    Methods Enzymol; 1985; 116():493-525. PubMed ID: 3937027
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of monocytes, alloantigens, and individual reactivity in the response of human lymphocytes to mitogenic factor.
    Ruiz P; Scornik JC
    J Immunol; 1982 Mar; 128(3):1289-95. PubMed ID: 6460059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandin E2 inhibits the generation of phytohemagglutinin-activated killer activity in human peripheral blood lymphocytes.
    Yamashita N; Ito M; Suzuki H; Sugiyama E; Yokoyama A; Sato M; Yano S
    Anticancer Res; 1986; 6(5):1113-6. PubMed ID: 3492171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor.
    Postlethwaite AE; Snyderman R; Kang AH
    J Exp Med; 1976 Nov; 144(5):1188-203. PubMed ID: 825607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
    Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
    Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
    [No Abstract]   [Full Text] [Related]  

  • 47. Reduction in mitogenic response of bovine lymphocytes by ketone bodies.
    Targowski SP; Klucinski W
    Am J Vet Res; 1983 May; 44(5):828-30. PubMed ID: 6603180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemical characterization of products of activated lymphocytes.
    Sorg C; Klinkert W
    Fed Proc; 1978 Nov; 37(13):2748-53. PubMed ID: 361438
    [No Abstract]   [Full Text] [Related]  

  • 49. An assay for human lymphocyte mitogenic factor: B-lymphocyte stimulation by a T-lymphocyte product.
    Littman BH; David JR
    Cell Immunol; 1978 Sep; 39(2):374-87. PubMed ID: 308860
    [No Abstract]   [Full Text] [Related]  

  • 50. Tyrosine phosphorylation of interleukin 2 receptor-related proteins in phytohemagglutinin-activated human lymphocytes.
    Ogawa R; Sugamura K; Watanabe Y
    Biochem Biophys Res Commun; 1987 Apr; 144(1):160-5. PubMed ID: 3034242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.
    Kerr MA; Hussein YM; Potts RC; Beck JS; Sheriff MM
    Immunology; 1987 Jun; 61(2):117-23. PubMed ID: 3596636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Stimulation of phosphoinositide turnover is an important but not a sole condition for activation of human T-lymphocyte proliferation by phytohemagglutinin and interleukin 2].
    Korichneva IL; Rudchenko SA; Krasnikova TL; Grigorian GIu; Smirnov VN
    Dokl Akad Nauk SSSR; 1989; 304(1):221-4. PubMed ID: 2544387
    [No Abstract]   [Full Text] [Related]  

  • 53. Mitogenic factor from chronically infected guinea pigs.
    Carlquist JF; Marcus S
    Immunol Commun; 1978; 7(5):567-79. PubMed ID: 308928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.
    Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ
    J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of mouse cells releasing or responding to mitogenic factor induced by phytomitogens in vitro.
    Jacobsson H; Blomgren H
    J Immunol; 1975 May; 114(5):1631-7. PubMed ID: 1079042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum leukocyte migration inhibitory activity and phytohemagglutinin stimulation of peripheral blood lymphocytes in paraproteinemia. A preliminary report.
    Petrini M; Ambrogi F; Polidori R; Azzarà A; Grassi B
    Boll Ist Sieroter Milan; 1981; 60(6):513-9. PubMed ID: 7046768
    [No Abstract]   [Full Text] [Related]  

  • 57. Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3.
    Smith CA; Rennick DM
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1857-61. PubMed ID: 2937061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Physicochemical properties of the human lymphocyte mitogenic factor induced by phytohemagglutinin].
    Voĭtenok NN; Varivotskaia NV; Murzenok PP; Potemkina ND
    Biull Eksp Biol Med; 1976 Aug; 82(8):963-5. PubMed ID: 1026298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor.
    Robb RJ
    Immunobiology; 1982 Mar; 161(1-2):21-50. PubMed ID: 7047366
    [No Abstract]   [Full Text] [Related]  

  • 60. Mitogenic and mitogenically defective phytohemagglutinin isolectins stimulate T-cell growth factor (interleukin 2) production and response in fresh and cultured human T lymphocytes.
    Hernandez DE; Leavitt RD
    Cell Immunol; 1984 Jun; 86(1):101-8. PubMed ID: 6609774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.